semaglutide recombinant synthesis Synthetic Routes Structure of semaglutide (subcutaneous formulation)

Owner: SINOPEP ALLSINO BIOPHARMACEUTICAL CO LTD Method for purifying sermaglutide The invention discloses a method for purifying sermaglutide

It is essential to discuss these potential risks and side effects with your healthcare provider to ensure it aligns with your health goals and conditions

The process as claimed in claim 1, wherein various amino acids of (3-31) amino acid fragment of Semaglutide are optionally protected with different protecting groups which include alkyloxy carbonyl such as methoxy carbonyl, ethoxy carbonyl, tert.butoxy carbonyl (Boc)

organic acids selected from tartaric acid, acetic acid, maleic acid, citric acid, malic acid, oxalic acid, formic acid, trifluoroacetic acid